Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia
Open accessThe DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index; 31 of the 126 sources its claims cite were checked for support.
Abstract
Human gut microbiota is able to influence the host physiology by regulating multiple processes, including nutrient absorption, inflammation, oxidative stress, immune function, and anabolic balance. Aging is associated with reduced microbiota biodiversity, increased inter-individual variability, and over-representation of pathobionts, and these phenomena may have great relevance for skeletal muscle mass and function. For this reason, the presence of a gut-muscle axis regulating the onset and progression of age-related physical frailty and sarcopenia has been recently hypothesized. In this narrative review, we summarize the studies supporting a possible association between gut microbiota-related parameters with measures of muscle mass, muscle function, and physical performance in animal models and humans. Reduced muscle mass has been associated with distinct microbiota composition and reduced fermentative capacity in mice, and the administration of probiotics or butyrate to mouse models of muscle wasting has been associated with improved muscle mass. However, no studies have targeted the human microbiome associated with sarcopenia. Limited evidence from human studies shows an association between microbiota composition, involving key taxa such as Faecalibacterium and Bifidobacterium, and grip strength. Similarly, few studies conducted on patients with parkinsonism showed a trend towards a different microbiota composition in those with reduced gait speed. No studies have assessed the association of fecal microbiota with other measures of physical performance. However, several studies, mainly with a cross-sectional design, suggest an association between microbiota composition and frailty, mostly assessed according to the deficit accumulation model. Namely, frailty was associated with reduced microbiota biodiversity, and lower representation of butyrate-producing bacteria. Therefore, we conclude that the causal link between microbiota and physical fitness is still uncertain due to the lack of targeted studies and the influence of a large number of covariates, including diet, exercise, multimorbidity, and polypharmacy, on both microbiota composition and physical function in older age. However, the relationship between gut microbiota and physical function remains a very promising area of research for the future.
Overview
CoChat Summary
TL;DR
This narrative review summarizes animal and human evidence for a gut-muscle axis linking gut microbiota to muscle mass, muscle function, and physical frailty/sarcopenia in aging. It concludes that the association is biologically plausible and supported by limited studies, but causality remains uncertain because targeted human studies are lacking and many covariates confound both microbiota and physical function.
Key findings
- Animal studies support a possible gut-muscle axis: reduced muscle mass has been associated with distinct microbiota composition and reduced fermentative capacity in mice, and probiotics or butyrate administration improved muscle mass in mouse models of muscle wasting.
- No studies have targeted the human microbiome specifically associated with sarcopenia; limited human evidence shows associations between microbiota composition, involving taxa such as *Faecalibacterium* and *Bifidobacterium*, and grip strength.
- In a randomized controlled trial of 60 nursing home residents, a prebiotic containing inulin and fructooligosaccharides improved hand-grip strength after 13 weeks (12.4 ± 3.2 vs. 10.2 ± 4.1 kg, p = 0.04), although fecal microbiota composition was not assessed.
- Frailty, mostly assessed by the deficit accumulation model/Rockwood Frailty Index, was associated with reduced microbiota biodiversity and lower representation of butyrate-producing bacteria; one trial in 50 nursing home residents found a mild but statistically significant reduction in a 62-item frailty index after prebiotic administration.
Methods
- Narrative review; papers searched on PubMed as of 1 June 2019 using terms including microbiota AND “muscle function,” sarcopenia, “muscle mass,” “muscle wasting,” frailty, “gait speed,” “muscle strength,” “grip strength,” and “physical performance.”
- A systematic review approach was not possible due to the low number of human studies and heterogeneity of settings, participants, and outcome measures; human studies relevant to the primary aim were discussed, with animal studies included for possible pathophysiological mechanisms.
- The review summarizes studies on microbiota-related parameters with measures of muscle mass, muscle function, and physical performance, including grip strength, gait speed, timed up-and-go, and frailty indices.
Limitations
- The paper states that the causal link between microbiota and physical fitness remains uncertain due to lack of targeted studies and the influence of many covariates, including diet, exercise, multimorbidity, and polypharmacy, on both microbiota composition and physical function in older age.
- The paper states that most human studies are cross-sectional, so causality cannot be inferred; no human studies have directly assessed an association between gut microbiota composition and skeletal muscle mass in age-related sarcopenia.
- The paper states that frailty studies mostly used the Rockwood Frailty Index or Clinical Frailty Scale, which do not directly assess muscle function and performance; gait speed studies were not focused on older people with sarcopenia or physical frailty and did not follow geriatric assessment recommendations.
- Evident from the text: this is a narrative rather than systematic review, with a search limited to 1 June 2019, and much of the mechanistic evidence comes from animal models whose translation to humans is uncertain.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
16 Valid · 6 Not valid · 66 Not checked · 21 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Healthy, active older subjects, including centenarians, show a microbiota composition resembling that of adult subjects, with limited features of dysbiosis [45,46].”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 1. Introduction > 1.2. Gut Microbiota: A Novel Player in Sarcopenia and Physical Frailty?
What the sources say
- Partly supportedcites [45] Kim S. Jazwinski S.M. The gut microbiota and healthy aging: A mini-review Gerontology 2018 64 513 520 10.1159/000490615 30025401 PMC6191326 sourceExperimental — accuracy not yet measured
In “The human gut microbiota” (page unavailable), the review says young adults and centenarians share a core microbiota, supporting a limited resemblance. But “Changes in the gut microbiota associated with longevity or healthy aging” (page unavailable) reports age-related compositional differences; it does not establish that healthy, active older people have an adult-like overall composition or only limited dysbiosis. (LLM, conf=0.84)
- Disputedcites [46] Biagi E. Nylund L. Candela M. Ostan R. Bucci L. Pini E. Nikkïla J. Monti D. Satokari R. Franceschi C. Through ageing, and beyond: Gut microbiota and inflammatory status in seniors and centenarians PLoS ONE 2010 5 e10667 10.1371/annotation/df45912f-d15c-44ab-8312-e7ec0607604d 20498852 PMC2871786 sourceExperimental — accuracy not yet measured
The Discussion (page not supplied) says young and elderly adults have comparable gut microbiota, but explicitly says centenarians differ significantly from the adult-like pattern and have lower diversity. The fecal-profile results likewise report significantly different microbiota profiles in centenarians. Thus the source contradicts the claim’s inclusion of centenarians. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Namely, the circulating levels of microbiota-derived indoxyl sulfate are positively associated with the expression of myostatin and atrogin-1 [29], representing two of the main negative regulators of skeletal muscle mass [30].”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 1. Introduction > 1.2. Gut Microbiota: A Novel Player in Sarcopenia and Physical Frailty?
What the sources say
- Partly supportedcites [29] Enoki Y. Watanabe H. Arake R. Sugimoto R. Imafuku T. Tominaga Y. Ishima Y. Kotani S. Nakajima M. Tanaka M. Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1 Sci. Rep. 2016 6 32084 10.1038/srep32084 27549031 PMC4994088 sourceExperimental — accuracy not yet measured
The Results (page not available in our copy) show that administering indoxyl sulfate increased myostatin and atrogin-1 expression in the skeletal muscle of half-nephrectomized mice. They do not establish a positive association between circulating indoxyl sulfate levels and expression: plasma trough levels only tended to rise in treated mice (p = 0.15). The cited study used administered indoxyl sulfate rather than testing a microbiota-derived exposure. (LLM, conf=0.86)
- Supportedcites [30] Sakuma K. Yamaguchi A. Sarcopenia and cachexia: Tha adaptations of negative regulators of skeletal muscle mass J. Cachexia Sarcopenia Muscle 2012 3 77 94 10.1007/s13539-011-0052-4 22476916 PMC3374017 source
The citation to this paper is attached to the description of myostatin and atrogin-1 as negative regulators of skeletal muscle mass, not to the preceding indoxyl-sulfate association, which cites [29]. The Sarcopenia section explicitly calls Atrogin-1 and myostatin common negative regulators; it does not need to establish the indoxyl-sulfate association to support the part attributed to [30]. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“the administration of probiotics or butyrate to mouse models of muscle wasting has been associated with improved muscle mass”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > Abstract
What the sources say
- Partly supportedcites [66] Varian B.J. Goureshetti S. Poutahidis T. Lakritz J.R. Levkovich T. Kwok C. Teliousis K. Ibrahim Y.M. Mirabal S. Erdman S.E. Beneficial bacteria inhibit cachexia Oncotarget 2016 7 11803 11816 10.18632/oncotarget.7730 26933816 PMC4914249 sourceExperimental — accuracy not yet measured
The Results (Figure 1; page unavailable) report improved muscle measures in a mouse model of cancer-associated cachexia after treatment with the probiotic L. reuteri. The Experimental design section describes L. reuteri administration, but our copy provides no evidence that butyrate was administered or improved muscle mass (searched: butyrate). (LLM, conf=0.88)
- Partly supportedcites [67] Bindels L.B. Beck R. Schackman O. Martin J.C. De Backer F. Sohet F.M. Dewulf E.M. Pachikian B.D. Neyrinck A.M. Thissen J.P. Restoring specific Lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model PLoS ONE 2012 7 e37971 10.1371/journal.pone.0037971 22761662 PMC3384645 sourceExperimental — accuracy not yet measured
The Results report that two Lactobacillus strains increased tibialis muscle weight by 8% in leukemic mice, although gastrocnemius weight did not change significantly. This supports the probiotic part of the claim for specific strains and one muscle; our copy does not report butyrate administration or its effect on muscle mass (searched: butyrate). (LLM, conf=0.88)
- Partly supportedcites [71] Walsh M.E. Bhattacharya A. Staranatarajan K. Qaisar R. Sloane L. Rahman M.M. Kinter M. Van Remmen H. The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging Aging Cell 2015 14 957 970 10.1111/acel.12387 26290460 PMC4693467 sourceExperimental — accuracy not yet measured
The section “Butyrate prevents hindlimb muscle loss during aging” reports that aged mice given butyrate lost less hindlimb muscle mass than controls. The Experimental procedures describe a butyrate-containing diet, not probiotic administration; our copy does not support the probiotic part of the claim. (LLM, conf=0.89)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Finally, transplantation of the intestinal microbiota from pigs to lean germ-free mice resulted in significant changes of muscle fibers structure, resembling to that typical of pigs [51].”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 2. Gut Microbiota and Muscle Mass > 2.1. The Microbiota as Transducer of Nutrient Signals
What the sources say
- Partly supportedcites [51] Yan H. Diao H. Xiao Y. Li W. Yu B. He J. Yu J. Zheng P. Mao X. Luo Y. Gut microbiota can transfer fiber characteristics and lipid metabolic profiles of skeletal muscle from pigs to germ-free mice Sci. Rep. 2016 6 31786 10.1038/srep31786 27545196 PMC4992887 sourceExperimental — accuracy not yet measured
The Results section ('The two groups of mouse recipients developed different body compositions, fiber characteristics and fiber type distributions') confirms that GF BALB/C mice colonized with porcine fecal suspension mirrored their pig donors in fiber type: MYH7 (slow type I) was higher and MYH4 (fast IIb) lower in RM versus YM at p < 0.05, and the Discussion states RP/RM exhibited higher type I and lower type IIb fibers. However, the morphological 'structure' measures the claim names — fiber diameter and cross-sectional area of the gastrocnemius — were only non-significant trends in both donors (p = 0.0994) and recipients (p = 0.0832), so 'significant changes of muscle fiber structure' overstates the source. Our copy also does not describe the germ-free recipients as 'lean'; the lean/obese contrast applies to the Yorkshire vs Rongchang pig donors. (LLM, conf=0.75)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The effects of protein intake on the gut microbiota composition, and the consequences for muscle mass deposition, may depend on protein quality and microbiota metabotype [54], so that the pro-anabolic response to protein intake, mediated by the microbiota, may be different on an individual basis.”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 2. Gut Microbiota and Muscle Mass > 2.1. The Microbiota as Transducer of Nutrient Signals
What the sources say
- Partly supportedcites [54] Liao Y. Peng Z. Chen L. Zhang Y. Cheng Q. Nüssler A.K. Bao W. Liu L. Yang W. Prospective views for whey protein and/or resistance training against age-related sarcopenia Aging Dis. 2019 10 158 174 10.14336/AD.2018.0325 30705776 PMC6345331 sourceExperimental — accuracy not yet measured
The section ‘Gut microbiota: a key factor for whey protein and/or resistance training against age-related sarcopenia?’ says protein quality affects gut microbiota in mice and discusses ways microbiota may influence skeletal muscle. It does not establish that the consequences for muscle mass deposition depend on protein quality or microbiota metabotype; the copy provides no page number for these passages. (LLM, conf=0.84)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
63 more claims · 7 with their cited sources checked
Create a free account to see all 109 claims and to verify the 95 references still open.
- It may state two separate claims as one. 37
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Anabolic resistance is associated with reduced gene expression in proteins involved in MPS, impaired protein absorption and digestion, loss of skeletal-muscle stem cells, and decreased amino-acid transportation in the skeletal muscle [19,137,138].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [19]
Experimental — accuracy not yet measuredIn the citing paper
“Gut microbiota dysbiosis is linked to age-related systemic inflammation, leading to impaired muscle function and increased proinflammatory cytokines, which are associated with higher risk of obesity [19].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 3. Gut Microbiota and Parameters of Muscle Function > 3.3. Gut Microbiota and Other Parameters of Physical Performance
“Similar intervention studies were performed in healthy adults, evaluating physical performance by measuring endurance capacity, which is not part of standard geriatric assessment [88,109].”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 3. Gut Microbiota and Parameters of Muscle Function > 3.1. Gut Microbiota and Muscle Strength
“In another experimental study, the administration of resveratrol, a polyphenol compound able to promote skeletal and cardiac muscle cell biogenesis and remodeling, to mouse models of heart failure resulted in significant changes in intestinal microbiota composition, but no improvement in muscle strength [88].”
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792
Clegg, A., Young, J., Iliffe, S., Rikkert, M. O., & Rockwood, K. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62167-9 · Cited by 9,503 · cited 1×
“This condition frequently overlaps with physical frailty [3], representing the reduction of the capacity to maintain fitness, physical performance and sense of well-being over time and particularly after stressors such as acute illnesses [4].”
BackgroundThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803 · cited 1×
“fractures, disability and mortality [1,2].”
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
Gut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314
Guralnik, J. M., Ferrucci, L., Pieper, C. F., Leveille, S. G., Markides, K. S., Ostir, G. V., Studenski, S., Berkman, L. F., & Wallace, R. B. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.4.m221 · Cited by 2,898
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615
Cited by
Items 101–200 of 418
Pacifico, L., Perla, F. M., Andreoli, G. M., Grieco, R., Pierimarchi, P., & Chiesa, C. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00158 · Cited by 41
“Alterations in the gut microbiota composition could in fact promote chronic inflammation and anabolic resistance, ultimately conditioning reduced muscle mass, impaired muscle function and adverse clinical outcomes (63).”
BackgroundYamamoto, K., Ishizu, Y., Honda, T., Ito, T., Imai, N., Nakamura, M., Kawashima, H., Kitaura, Y., Ishigami, M., & Fujishiro, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-07810-3 · Cited by 39
Tricarboxylic Acid Cycle Intermediates and Individual Ageing
Kurhaluk, N. (2024) · Biomolecules · doi:10.3390/biom14030260 · Cited by 36
“…during ageing is a phenomenon in which cells consume their own components (organelles) as a fuel source, and it is associated with dysregulation of splicing, which builds RNA from DNA, disturbances in the microbiome [39], and dysfunction of laminin, i.e., the nuclear envelope protecting DNA.”
BackgroundTicinesi, A., Nouvenne, A., Cerundolo, N., Parise, A., & Meschi, T. (2023) · Nutrients · doi:10.3390/nu15102367 · Cited by 38
“The interaction between polyphenols and intestinal microbiota could consistently increase the variability of physiological responses to dietary polyphenol supplementation, especially in older individuals who are particularly prone to gut microbiota dysbiosis [50,51,267].”
BackgroundSelf-citationDietary Patterns, Gut Microbiota and Sports Performance in Athletes: A Narrative Review
Chen, Y., Yang, K., Xu, M., Zhang, Y., Weng, X., Luo, J., Li, Y., & Mao, Y.-H. (2024) · Nutrients · doi:10.3390/nu16111634 · Cited by 53
“These changes encompass alterations in carbohydrate and protein fermentation, intestinal inflammation, fat oxidation, as well as an increase in amino acid availability, potentially promoting protein anabolism [46,68–71].”
BackgroundZhang, Z., Guo, Q., Yang, Z., Sun, Y., Jiang, S., He, Y., Li, J., & Zhang, J. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115265 · Cited by 51
Investigation of the Diet-Gut-Muscle Axis in the Osteoporotic Fractures in Men Study
Barger, K., Langsetmo, L., ORWOLL, E. S., & Lustgarten, M. S. (2020) · The journal of nutrition health & aging · doi:10.1007/s12603-020-1344-1 · Cited by 37
“A role for the gut microbiome on the maintenance of whole body lean mass, skeletal muscle mass, and physical function (defined as the gut-muscle axis) has been proposed by several independent research groups (1-5).”
BackgroundGut-muscle axis and sepsis-induced myopathy: The potential role of gut microbiota
Liu, Y., Xu, L., Yang, Z., Wang, D., Li, T., Yang, F., Li, Z., Bai, X., & Wang, Y.-C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114837 · Cited by 34
Olteanu, G., Pană, M.-A., Busnatu, Ș., Lupuliasa, D., Neacșu, S. M., Mititelu, M., Musuc, A. M., Ioniță-Mîndrican, C.-B., & Boroghină, S. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105561 · Cited by 39
Age-related diseases, therapies and gut microbiome: A new frontier for healthy aging
Barone, M., D’Amico, F., Rampelli, S., Brigidi, P., & Turroni, S. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111711 · Cited by 34
Adipose tissue in older individuals: a contributing factor to sarcopenia
Wang, T., Zhou, D., & Hong, Z. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155998 · Cited by 40
Pathobiology of frailty in lung disease
Koons, B., Greenland, J. R., Diamond, J. M., & Singer, J. P. (2020) · Translational research · doi:10.1016/j.trsl.2020.04.001 · Cited by 36
An Updated View of the Effect of Probiotic Supplement on Sports Performance: A Detailed Review
Aykut, M. N., Erdoğan, E. N., Çelik, M. N., & Gürbüz, M. (2024) · Current Nutrition Reports · doi:10.1007/s13668-024-00527-x · Cited by 39
Wen, N.-N., Sun, L., Qian, G., & Zheng, G.-H. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i35.6815 · Cited by 40
Muscle aging amelioration by yeast protein supplementation was associated with gut microbiota
Liao, Y., Zhou, X., Peng, Z., Li, D., Meng, Z., Xu, S., Yang, X., Liu, L., & Yang, W. Q. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.104948 · Cited by 30
Butyrate promotes C2C12 myoblast proliferation by activating ERK/MAPK pathway
Guan, L., Cao, Z., Pan, Z., Zhao, C., Xue, M., Yang, F., & Chen, J. (2023) · Molecular Omics · doi:10.1039/d2mo00256f · Cited by 33
Hao, W., Cha, R., Wang, M., Li, J., Guo, H., Du, R., Zhou, F., & Jiang, X. (2023) · ACS Nano · doi:10.1021/acsnano.3c01656 · Cited by 30
Physical activity‐induced alterations of the gut microbiota are BMI dependent
Shah, S., Mu, C., Moossavi, S., Shen‐Tu, G., Schlicht, K., Rohmann, N., Geisler, C., Laudes, M., Franke, A., Züllig, T., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202201571r · Cited by 37
Effect of Gut Microbiota-Mediated Tryptophan Metabolism on Inflammaging in Frailty and Sarcopenia
Xu, Y., Mao, T., Wang, Y., Qi, X., Zhao, W.-J., Chen, H., Zhang, C., & Li, X. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae044 · Cited by 33
The gut microbiome, chronic kidney disease, and sarcopenia
Zheng, G., Cao, J., Wang, X. H., He, W., & Wang, B. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01922-1 · Cited by 35
“The gut microbiota may have detrimental effects on muscle mass and function by inducing anabolic imbalances, insulin resistance, promoting chronic systemic inflammation [65, 66].”
de la Barquera, B. S. Y. S., Carrillo, B. E. M., Garrido, J. F. A., Martínez-Méndez, R., Arciniega, A. D. B., Valdés‐Ramos, R., & Piña, A. E. S. (2022) · The journal of nutrition health & aging · doi:10.1007/s12603-022-1842-4 · Cited by 38
“Ticinesi and collaborators (33) showed that the bacterial taxa associated with frailty syndrome include the following: Prevotella, Ruminococcus, Alistipes, Oscillibacter, Eubacterium, Eggerthella, Faecalibacterium, Coprobacillus, Porphyromonas, Peptococcus, Fonticella, Clostridium cluster XIVa,…”
The animal protein hydrolysate attenuates sarcopenia via the muscle-gut axis in aged mice
Lee, J.-Y., Shin, S., Bae, H. R., Ji, Y., Park, H.-J., & Kwon, E. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115604 · Cited by 29
Chen, F., Li, Q., Chen, Y., Wei, Y., Liang, J., Song, Y., Shi, L., Wang, J., Mao, L., Zhang, B., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002697rrr · Cited by 29
He, Y., Cui, W., Fang, T., Zhang, Z., & Min De, Z. E. N. G. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1301805 · Cited by 30
Jiang, H., Lin, X., Liang, W. H., Li, Y., & Yu, X. H. (2022) · Nutrients · doi:10.3390/nu14081673 · Cited by 25
“In addition, decreased immune function in elderly patients is associated with disturbances in the gut microbiota, which may be related to pain in bone and joint diseases [20,21].”
BackgroundAraújo, L. P., Godoy, A. C. F., Frota, F. F., Lamas, C. B., Quesada, K. R., Detregiachi, C. R. P., Araújo, A. C., Miglino, M. A., Guiguer, É. L., Haber, R. S. D. A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412147 · Cited by 40
“The gut–brain axis also affects skeletal muscles, forming the microbiota-gut-muscle axis [214,215].”
Priori, E. C., Ratto, D., Luca, F. D., Sandionigi, A., Savino, E., Giammello, F., Romeo, M., Brandalise, F., Roda, E., & Rossi, P. (2023) · Biology · doi:10.3390/biology13010018 · Cited by 32
“Recent research demonstrated that the gut microbiota composition undergoes significant changes during ageing, which strongly correlates with age-related ailments like frailty [25–27].”
BackgroundKang, M., Kang, M., Yoo, J., Lee, J., Lee, S., Yun, B., Song, M., Kim, J., Kim, H., Yang, J., et al. (2024) · Food & Function · doi:10.1039/d3fo05420a · Cited by 29
Chen, H., Xu, C., Zhang, F., Liu, Y., Guo, Y., & Yao, Q. (2020) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04060-w · Cited by 27
Sepsis-Induced Myopathy and Gut Microbiome Dysbiosis: Mechanistic Links and Therapeutic Targets
Mankowski, R. T., Laitano, O., Darden, D. B., Kelly, L. S., Munley, J. A., Loftus, T. J., Mohr, A. M., Efron, P. A., & Thomas, R. M. (2021) · Shock · doi:10.1097/shk.0000000000001843 · Cited by 27
“Recent preclinical evidence demonstrates a cross-talk between the gut microbial environment and the skeletal muscle (43, 44).”
BackgroundBoytar, A. N., Nitert, M. D., Morrison, M., Skinner, T. L., & Jenkins, D. G. (2022) · The Journal of Physiology · doi:10.1113/jp283702 · Cited by 29
“Myokines produced by exercising muscle have been implicated in reducing cancer risk (Badal et al., 2020; Lochlainn et al., 2018; Shin et al., 2019; Ticinesi et al., 2017; Ticinesi et al., 2019; Watson et al., 2021).”
BackgroundZhang, Y., Zhu, Y., Guo, Q., Wang, W., & Zhang, L. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112287 · Cited by 28
“These mechanisms include the regulation of amino acid synthesis, the expression of inflammatory factors, DNA synthesis or methylation, oxidative stress, insulin sensitivity, anabolism, and cell proliferation (Ticinesi et al., 2019).”
Barry, D. J., Wu, S. S. X., & Cooke, M. B. (2024) · Nutrients · doi:10.3390/nu17010081 · Cited by 23
Research progress of gut microbiota and frailty syndrome
Wang, X. Q., & Wu, M. (2021) · Open Medicine · doi:10.1515/med-2021-0364 · Cited by 25
Monoterpenes as Sirtuin-1 Activators: Therapeutic Potential in Aging and Related Diseases
Sousa, C., & Mendes, A. F. (2022) · Biomolecules · doi:10.3390/biom12070921 · Cited by 26
Puerarin improves skeletal muscle strength by regulating gut microbiota in young adult rats
Yang, W., Gao, B., Qin, L., & Wang, X. (2022) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2022.08.009 · Cited by 26
“Gut microbes influence skeletal muscle strength and physical performance in animals [40].”
BackgroundCotarelo, M., Jackson-Akers, J. Y., Nagy-Agren, S. E., & Warren, C. A. (2023) · European journal of medical research · doi:10.1186/s40001-023-01432-9 · Cited by 25
Age-related sarcopenia and altered gut microbiota: A systematic review
Wang, M., Ren, F., Zhou, Y., He, Y., Du, T., & Tan, Y. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106850 · Cited by 28
Exploring the Relationship Between Gut Microbiota and Sarcopenia Based on Gut–Muscle Axis
Li, W., Sheng, R., Cao, M., & Rui, Y. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4550 · Cited by 36
The recent development, application, and future prospects of muscle atrophy animal models
Zhang, G., Hu, F., Huang, T., Ma, X., Cheng, Y., Liu, X., Jiang, W., Dong, B., & Fu, C. (2024) · MedComm – Future Medicine · doi:10.1002/mef2.70008 · Cited by 35
Vitamin biosynthesis in the gut: interplay between mammalian host and its resident microbiota
Tarracchini, C., Lordan, C., Milani, C., Moreira, L. D. P. D., Alabedallat, Q. M., de LeBlanc, A. D. M., Turroni, F., Lugli, G. A., Mancabelli, L., Longhi, G., et al. (2025) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00184-23 · Cited by 34
The Ketogenic Diet: Is It an Answer for Sarcopenic Obesity?
Ilyas, Z., Perna, S., Alalwan, T. A., Zahid, M. N., Spadaccini, D., Gasparri, C., Peroni, G., Faragli, A., Alogna, A., Porta, E. L., et al. (2022) · Nutrients · doi:10.3390/nu14030620 · Cited by 23
“According to studies, the gut microbiota’s resilience declines around the age of 65, making its overall composition more sensitive to lifestyle changes, pharmacological therapy such as antibiotics, and disease [61].”
BackgroundLee, P., Lee, K., Yang, T., Lu, H., Cheng, T.-Y., Chen, Y.-J., Chiou, J.-J., Huang, C.-W., Yang, U., Tan, E. C., et al. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100619 · Cited by 24
“JHEP Reports 2023 to be important for maintaining gut barrier function(30) and is positively associated with healthier muscle mass and function.(31) It is also reportedly less abundant in individuals with overt HE or alcohol-related liver disease.”
BackgroundTeker, H. T., Ceylani, T., Keskin, S., Samgane, G., Mansuroğlu, S., Baba, B., Allahverdi, H., Açıkgöz, E., & Gurbanov, R. (2023) · Biogerontology · doi:10.1007/s10522-023-10032-3 · Cited by 22
Ispoglou, T., Wilson, O. J., McCullough, D., Aldrich, L., Ferentinos, P. P., Lyall, G. K., Stavropoulos‐Kalinoglou, A., Duckworth, L. C., Brown, M. A., Sutton, L., et al. (2023) · Biology · doi:10.3390/biology12070892 · Cited by 29
Gut Microbiota Regulates Brain–Bone Axis to Influence Osteoporosis Pathogenesis and Treatment
Shi, H., Huang, L., Zhang, J. H., Shen, C., Zhang, N., Lv, C., Shao, L., Li, M., Sun, Z., Shi, L., et al. (2026) · Research · doi:10.34133/research.1178 · Cited by 32
“In parallel, gut microbial imbalance may compromise neuromuscular function and skeletal muscle maintenance, thereby indirectly weakening bone quality [ 16 ].”
Farsijani, S., Cauley, J. A., Peddada, S., Langsetmo, L., Shikany, J. M., ORWOLL, E. S., Ensrud, K. E., Cawthon, P. M., & Newman, A. B. (2022) · Journal of Nutrition · doi:10.1093/jn/nxac231 · Cited by 22
Visuthranukul, C., Leelahavanichkul, A., Tepaamorndech, S., Chamni, S., Mekangkul, E., & Chomtho, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-61781-1 · Cited by 23
“Previous study reported that Bacteroides was positively associated with parameter of muscle function 41 , while a decrease in the genus Akkermansia was found in the gut microbiota of sarcopenia patients with cirrhosis 45 .”
BackgroundResultA Cross-Sectional Study of the Gut Microbiota Composition in Moscow Long-Livers
Kashtanova, D. A., Klimenko, N. S., Strazhesko, I. D., Starikova, E. V., Glushchenko, O. E., Андреевич, Г. Д., & Ткачева, О. Н. (2020) · Microorganisms · doi:10.3390/microorganisms8081162 · Cited by 23
“, in patients with a negative aging scenario [3].”
BackgroundYang, Y., Che, K., Deng, J., Tang, X., Jing, W., He, X., Yang, J., Zhang, W., Yin, M., Pan, C., et al. (2024) · JMIR Public Health and Surveillance · doi:10.2196/59762 · Cited by 27
“Furthermore, previous findings suggest that aging-associated microbiota can promote intestinal permeability and inflammation and eventually increase the levels of frailty-related proinflammatory cytokines [42,43].”
BackgroundSarcopenia in cirrhosis: From pathophysiology to interventional therapy
Chen, H., Yang, C., Yan, S., Liu, X., Zhou, L., & Yuan, X. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112571 · Cited by 30
“Sarcopenia is associated with the gut microbiota in addition to its many effects on host physiological systems (Ticinesi et al., 2019; Strasser et al., 2021; Park et al., 2021).”
BackgroundYasueda, A., Sekido, Y., Takeda, T., Ogino, T., Miyoshi, N., Takahashi, H., Uemura, M., Doki, Y., Eguchi, H., & Mizushima, T. (2021) · Nutrition · doi:10.1016/j.nut.2021.111526 · Cited by 22
Guo, Y. P., Zhu, G., Wang, F., Zhang, H., Chen, X., Mao, Y., Lv, Y., Xia, F., Jin, Y., Ding, G.-X., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.827174 · Cited by 24
“(18) showed that frailty was associated with reduced microbiota biodiversity and low representation of butyrate-producing bacteria.”
BackgroundLi, C., Li, Y., Wang, N., Ge, Z., Shi, Z., Wang, J., Ding, B., Bi, Y., Wang, Y., & Hong, Z. (2022) · Healthcare · doi:10.3390/healthcare10061100 · Cited by 22
“Recently, with the rising hypothesis of gut microbiota (GM)–muscle axis, GM has been considered as a novel modulator of skeletal muscle health [15].”
BackgroundChen, D., Han, H., Sun, X., Zhou, G., Zhou, Q., & Li, Z. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1238800 · Cited by 24
Approach to COVID-19 in older adults and indications for improving the outcomes
Tana, C., Moffa, L., Falasca, K., Vecchiet, J., Tana, M., Mantini, C., Ricci, F., Ticinesi, A., Meschi, T., Cipollone, F., et al. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2265298 · Cited by 27
“WHO defines frailty as a condition characterized by an increased aged-related vulnerability due to a reduced physiological reserve and function of systemic organs, and is associated with an impairment of activities of daily living (ADL) [5–10].”
BackgroundSelf-citationZhang, Q., Liu, S., Yuan, C., Sun, F., Zhu, S., Guo, S., Wu, S., & Zhang, S. (2023) · Annals of Epidemiology · doi:10.1016/j.annepidem.2023.10.006 · Cited by 20
Gut dysbiosis impacts the immune system and promotes prostate cancer
Shyanti, R. K., Greggs, J., Malik, S., & Mishra, M. K. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106883 · Cited by 26
Hai, C., Hao, Z., Bu, L., Lei, J., Liu, X., Zhao, Y., Bai, C., Su, G., Yang, L., & Li, G. (2024) · Communications Biology · doi:10.1038/s42003-024-07252-9 · Cited by 27
“Inrecentyears,therehasbeenincreasinginterestin understandingthepotentialconnectionbetweenthegutmicrobiotaand musclefunction 1 .”
Liu, C., Yang, Y., Guo, S., Cao, Y., Wang, L., & Wu, C. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.07.033 · Cited by 26
“Through the gut-bone axis, the gut microbiome can modify nutrient absorption, the release of metabolites, and the secretion of hormone, thus regulate bone growth and development [20– 22].”
Acute sarcopenia changes following hospitalization: influence of pre-admission care dependency level
Spiegeleer, A. D., Kahya, H., Sánchez‐Rodríguez, D., Piotrowicz, K., Surquin, M., Marco, E., Detremerie, C., Hussein, D., Hope, S. V., Dallmeier, D., et al. (2021) · Age and Ageing · doi:10.1093/ageing/afab163 · Cited by 23
Sarcopenia: An Age-Related Multifactorial Disorder
Priyadarsini, N., Nanda, P., Devi, S., & Mohapatra, S. (2022) · Current Aging Science · doi:10.2174/1874609815666220304194539 · Cited by 23
Chang, S.-S., Chen, L., Huang, K., Huang, S.-W., Chang, C., Liao, K., Hu, E.-C., Chen, Y., Chen, Y., Hsu, P.-C., et al. (2023) · Food & Function · doi:10.1039/d3fo02766j · Cited by 28
Delaire, L., Courtay, A., Humblot, J., Aubertin‐Leheudre, M., Mourey, F., Racine, A. N., Gilbert, T., Niasse‐Sy, Z., & Bonnefoy, M. (2023) · Nutrients · doi:10.3390/nu15194100 · Cited by 37
Gut microbiota influence frailty syndrome in older adults: mechanisms and therapeutic strategies
Wang, X., Fan, L., Meng, C., Wang, Y., Deng, L.-E., Yuan, Z., Zhang, J., Li, Y., & Lv, S. (2023) · Biogerontology · doi:10.1007/s10522-023-10082-7 · Cited by 21
“…increased intestinal permeability, resulting in an impaired function of the barrier of intestine and consequently contributing to the translocation of microorganisms and harmful substances, such as LPS, into the body’s circulation (Thevaranjan et al. 2017; Sovran et al. 2019; Ticinesi et al. 2019).”
Rondanelli, M., Gasparri, C., Cavioni, A., Sivieri, C., Barrile, G. C., Mansueto, F., & Perna, S. (2024) · Nutrients · doi:10.3390/nu16091369 · Cited by 23
“Moreover, recently, there has been a growing interest from the scientific community regarding the role that gut microbiota could play in the pathophysiology of sarcopenia, hypothesizing the existence of a real gut–muscle axis [4].”
BackgroundThe Oral–Gut Microbiota Axis as a Mediator of Frailty and Sarcopenia
Azzolino, D., Schianca, M. C., Bottalico, L., Colella, M., Felicetti, A., Perna, S., Terranova, L., García-Godoy, F., Rondanelli, M., Passarelli, P. C., et al. (2025) · Nutrients · doi:10.3390/nu17152408 · Cited by 23
“Over the last decade, there has been an increasing research interest on the potential role of gut microbiota in influencing a wide range of conditions, including the age-related muscle decline (i.e., sarcopenia), poor nutritional status and frailty [1–4].”
InfluentialMobeen, F., Sharma, V., & Prakash, T. (2020) · 3 Biotech · doi:10.1007/s13205-020-02376-1 · Cited by 24
“The Vata individuals have also been found to exhibit irregular appetite than the other Prakriti classes (Travis and Wallace 2015).”
Gut microbiota in relation to frailty and clinical outcomes
D’Amico, F., Barone, M., Brigidi, P., & Turroni, S. (2023) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000926 · Cited by 26
A meta‐analysis of the effect of probiotic administration on age‐related sarcopenia
Mashhadi, N. S., Navab, F. S., Ansari, S., Rouhani, M. H., Hajhashemy, Z., & Saraf‐Bank, S. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3515 · Cited by 22
Maged, N. A., Hasanien, H. M., & Alharbi, M. (2024) · Ain Shams Engineering Journal · doi:10.1016/j.asej.2024.102855 · Cited by 18
Characterization of the gut microbiota in hemodialysis patients with sarcopenia
Zhou, Q., Zhang, H., Yin, L., Li, G., Liang, W., & Chen, G. (2021) · International Urology and Nephrology · doi:10.1007/s11255-021-03056-6 · Cited by 21
The relationship between the gut microbiome and resistance training: a rapid review
Wagner, A., Kapounková, K., & Struhár, I. (2024) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-023-00791-4 · Cited by 21
“The gut-muscle axis represents a complex system with many factors at play [62].”
BackgroundKim, D., Xu, H., Li, O., Xue, M., Bao, Z., & Yang, F. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177105 · Cited by 20
Symptoms related to gastrointestinal tract involvement and low muscularity in systemic sclerosis
Rosato, E., Gigante, A., Pellicano, C., Villa, A., Iannazzo, F., Fegatelli, D. A., & Muscaritoli, M. (2022) · Clinical Rheumatology · doi:10.1007/s10067-022-06059-5 · Cited by 19
“In particular, data exist suggesting that in older adults, gut dysbiosis is associated with increased intestinal permeability, favoring the passage of endotoxin and other microbial factors into the circulation, thus prompting systemic inflammation, in turn promoting the loss of muscle mass [32, 33].”
BackgroundZhu, R., Ouyang, Y., Chen, Y., Zhang, L., Nie, J., Farag, M. A., Çapanoğlu, E., & Zhao, C. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123465 · Cited by 17
Sarcopenic obesity in liver disease: Handling both sides of the penny
Hui, Y., Cui, B., Wang, X., Sun, M., Li, Y., Yang, W., Guo, G., Mao, L., Yu, Z., Fan, X., et al. (2022) · Portal hypertension & cirrhosis · doi:10.1002/poh2.10 · Cited by 19
Gong, H., Duan, S., Lin, X., & Huang, S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1514209 · Cited by 17
A Comprehensive Review of the Triangular Relationship Among Diet, Gut Microbiota, and Aging
Ramasinghe, C., Bordiga, M., & Xu, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188785 · Cited by 26
“The SCFAs that were produced by these taxa contributed to the improvement of muscle strength and preservation through enhanced mitochondrial function and anabolic muscle signaling [66].”
Han, J.-W., Shin, S., Bae, H. R., Lee, H., Moon, S. Y., Seo, W. D., & Kwon, E. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155747 · Cited by 23
Leaky Gut Syndrome: An Interplay Between Nutrients and Dysbiosis
Marcari, A. B., Paiva, A. D., Simon, C. R., & dos Santos, M. E. S. M. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00614-7 · Cited by 18
“It leads to increased microbial translocation into the systemic circulation, causing systemic inflammation and significant clinical outcomes such as metabolic syndrome, decreased physical function, and increased mortality [66, 67].”
Lettieri, M., Rosa, A., Spataro, F., Capria, G., Barnaba, P., GARGARI, M., & Martelli, M. (2025) · Nutrients · doi:10.3390/nu17152507 · Cited by 28
“…ability had lower caloric and nutrient intakes (except for refined carbohydrates), and a higher prevalence of signs of protein-energy malnutrition; this association remained significant after adjusting for confounding variables such as age, cognitive status, tooth number, and comorbidities [12].”
The Effect of Metabolites on Mitochondrial Functions in the Pathogenesis of Skeletal Muscle Aging
Gu, X., Wang, W., Yang, Y., Lei, Y., Liu, D., Wang, X., & Wu, T. (2022) · Clinical Interventions in Aging · doi:10.2147/cia.s376668 · Cited by 15
Boopathi, S., Priya, P. S., Haridevamuthu, B., Nayak, S. P. R. R., Chandrasekar, M., Arockiaraj, J., & Jia, A. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106856 · Cited by 17
Huang, P., Yeh, C., Yang, S., Shirakawa, H., Chang, C., Chen, L., Chiu, Y.-S., & Chiu, W. (2023) · Nutrients · doi:10.3390/nu15163514 · Cited by 19
Han, S., Seo, K., Lee, H. G., & Kim, H. (2023) · Food Research International · doi:10.1016/j.foodres.2023.113476 · Cited by 21
Lou, J., Wang, Q., Wan, X., & Cheng, J. (2023) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14661 · Cited by 17
Fecal Microbiota Transplantation Attenuates Frailty via Gut-Muscle Axis in Old Mice
Zhu, M., Huang, Y., Wang, Z., Jin, Z., Cao, J., Zhong, Q., & Xiong, Z. (2024) · Aging and Disease · doi:10.14336/ad.2024.0321 · Cited by 31
“Although the causal relationship remains uncertain, results from animal and human studies support the presence of a gut-muscle axis actively involved in the pathophysiology of frailty and sarcopenia, i.e. the gut-muscle axis [13].”
Zhang, Q., Ma, J.-D., Lu, Y., Zhang, R.-N., Zhao, Z., Li, Y.-T., & Chen, Q. (2024) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v16.i6.1857 · Cited by 17
Jeong, Y., Kim, J., Jung, Y., Kwak, M., Sung, M., & Imm, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137499 · Cited by 20
The microbiome links between aging and lupus
Katz-Agranov, N. S., & Zandman‐Goddard, G. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102765 · Cited by 15
Ren, Y., He, X., Wang, L., & Chen, N. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1480293 · Cited by 39
“This imbalance of gut microbiota is particularly prevalent in older people, attributed to age-related factors such as malnutrition, physical inactivity, chronic disease, and polypharmacy (Vaiserman et al., 2017; Ticinesi et al., 2019; Gemikonakli et al., 2021).”
InfluentialMoffa, L., & Tana, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199649 · Cited by 21
Self-citationImmune Remodeling during Aging and the Clinical Significance of Immunonutrition in Healthy Aging
Dou, L., Yang, P., Zhang, B., Yang, H., & Zheng, K. (2023) · Aging and Disease · doi:10.14336/ad.2023.0923 · Cited by 24
Zhang, Q., Li, X., Huang, T., Zhang, S., Teng, K., Rousitemu, N., Lan, T., & Wen, Y. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112376 · Cited by 14
Zeng, Y., He, X., Peng, X., Zhao, L., Yin, C., & Mao, S. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s462594 · Cited by 14
“101 Moreover, specific gut microbiota can reduce inflammation through the production of short-chain fatty acids, contribute to the maintenance of skeletal muscle quality, and improve skeletal muscle function.”
BackgroundHuang, J., Liu, S., Li, P., Wei, L., Lin, G., Lin, J., Luo, Y., Liu, Y., Mao, Y., Ruan, H., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107385 · Cited by 18
Li, Y., Wang, S., Quan, K., Ma, D., Zhang, H., Zhang, W., Chen, Z., Kwok, L. Y., Zhang, Y., & Sun, Z. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105161 · Cited by 13
Zavyalova, A. N., Новикова, В. П., & Ignatova, P. D. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-207-11-60-69 · Cited by 13
Pan, W., Du, J., An, L., Xu, G., Yuan, G., Sheng, Y., Sun, J., Wang, M., Zhao, N., Guo, X. L., et al. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3316 · Cited by 12
“The ability of the gut microbiota to regulate the organism will gradually weaken with age (Ticinesi et al., 2019).”
Background
Metadata
- Authors
- Ticinesi, A., Nouvenne, A., Cerundolo, N., Catania, P., Prati, B., Tana, C., & Meschi, T.
- Affiliations
- University of Parma (IT)
- Ospedale di Parma (IT)
- Corresponding author
- Ticinesi, Andrea
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-07-17
- Volume
- 11
- Issue
- 7
- Pages
- 1633
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6683074
- OpenAlex
- W2961066137
- Semantic Scholar
- fecf6f6df4b36ccd42a489508be21efdeb7072a1
- Cited by
- 418
- References
- 144
- Citations by year
- 2026: 60 · 2025: 61 · 2024: 88 · 2023: 73 · 2022: 49 · 2021: 44 · 2020: 36 · 2019: 6
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Keywords
- gut microbiota, aging, sarcopenia, physical frailty, muscle mass, muscle function, gut-muscle axis, microbiome diversity, butyrate, probiotics, Faecalibacterium, Bifidobacterium, grip strength, walking speed, parkinsonism, physical performance
- MeSH terms
- Gastrointestinal Microbiome, Frailty, Aged, Animals, Humans, Muscle, Skeletal, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
